Inspire Medical Systems, Inc. Announces Second Quarter 2020 Financial ResultsĀ and Updates 2020 Outlook

Go back to Inspire Medical Systems, Inc. Announces Second Quarter 2020 Financial ResultsĀ and Updates 2020 Outlook

Inspire Medical Systems (INSP) PT Raised to $50 at Oppenheimer

August 5, 2020 7:08 AM EDT

Oppenheimer analyst Suraj Kalia raised the price target on Inspire Medical Systems (NYSE: INSP) to $50.00 (from $42.00) while maintaining a Underperform rating.

The analyst commented, "Inspire reported 2Q revenues/GAAP EPS of $12.2M/($0.88), behind our estimates of $14.1M/($0.79), but ahead of consensus of $7.9M/($1.07)E,... More

Inspire Medical Systems (INSP) Tops Q2 EPS by 22c, Revenues Beat; Offers FY20 Revenue Guidance Above Consensus

August 4, 2020 5:42 PM EDT

Inspire Medical Systems (NYSE: INSP) reported Q2 EPS of ($0.88), $0.22 better than the analyst estimate of ($1.10). Revenue for the quarter came in at $12.2 million versus the consensus estimate of $7.85 million.

Recent Business Highlights

Generated revenue of $12.2 million in the second quarter of 2020, a 32% decrease over the same quarter last yearActivated 16 new U.S. medical centers in the second quarter of 2020Created nine new territories in the second quarter of 2020, bringing the total to 91 U.S. territoriesAnnounced that all seven Medicare Administrative Contractors' ("MACs") final Local Coverage Determinations ("LCDs") became... More